IPOs in Life Sciences

Lexology November 26, 2024
Bird & Bird

The amount of capital required to develop and bring a drug to market is significant. It is estimated that it costs US$1-2 billion to successfully take a drug from invention through all the clinical trials required to obtain the regulatory approvals and start the commercialisation process. Similarly, it costs many millions of dollars to complete the testing and obtain the regulatory approvals necessary to market a medical device.

While many life sciences companies initially look to private capital for funding, there are many who turn to the public markets to raise capital; whether they have exhausted their private funding options or because they want to reach a broader investor base. This is particularly true for growth companies that have generated...

Today's Sponsors

Today's Sponsor